GKB Ophthalmics Ltd — Updates, 28-07-2025: Company Update

GKB Ophthalmics reported significantly increased net losses for FY25: ₹6.11 Cr standalone and ₹7.08 Cr consolidated, despite revenue growth. Key financial ratios like Return on Networth and Debt-Equity worsened. The company is focused on plastic lenses, investing in new machinery for export orders, and seeking a ₹7.50 Cr term loan for expansion. Auditors highlighted concerns regarding electronic record-keeping, delayed statutory payments, and discrepancies in bank filings. Shareholders will consider expanding borrowing limits and approving notable related-party transactions, including a subsidiary CEO's remuneration and revised transaction limits with Lensco. The credit rating remains 'CRISIL D'.